tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Stock Investors

257 Followers
Based on 728,053 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MLTX
On average, investors allocate 3.54% of their portfolios to MLTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,053 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MLTX

1.4%
Last 7
Days
2.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MLTX, out of 728,053 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MLTX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.44%
$40.18
Increased
100.00%
$46.38
Opened
1.72%
$62.50
Based on the activity of 13,678 investors who made their portfolios public
The table shows changes in MLTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MLTX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Riot Platforms
4.85%
-0.72%
+1.41%
2.31B
Financial
Trade Desk
4.77%
-0.70%
-2.23%
42.23B
Technology
Marvell
4.88%
+1.43%
+7.26%
60.76B
Technology
Arista Networks
4.24%
-0.29%
-1.44%
84.79B
Technology
Novo Nordisk
5.46%
+0.07%
-1.55%
562.72B
Healthcare
DraftKings
7.11%
-0.88%
-2.94%
38.32B
Consumer Cyclical
UnitedHealth
4.46%
-0.12%
-0.80%
404.91B
Healthcare
ServiceNow
4.03%
-0.56%
-0.52%
157.59B
Technology
Merck & Company
4.12%
-0.31%
-0.70%
318.45B
Healthcare
GE Aerospace
5.47%
+1.21%
+5.28%
169.05B
Industrials
Based on the activity of 728,053 active portfolios
Open your Smart Portfolio

MLTX Investor Analysis

MLTX investors under 35

Under 35

7.0%
Last 30 days
Holdings Change
25.0%
of MLTX holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
MLTX investors between 35–55

Between 35–55

5.9%
Last 30 days
Holdings Change
34.4%
of MLTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
MLTX investors over 55

Over 55

14.0%
Last 30 days
Holdings Change
40.6%
of MLTX holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of MLTX stock investors
See who invests in MLTX according to age group and performance.

FAQ

How many retail Investors hold MLTX?
<0.1% of TipRanks' retail investors hold MLTX in their portfolios.
    What is MLTX Investor Sentiment?
    MLTX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of MLTX in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of MLTX in the last 7 days.
        What percentage of retail investors changed their holding of MLTX in the last 30 days?
        ▼ 2.2% of TipRanks' retail investors changed their holding of MLTX in the last 30 days.
          What is the average age of retail investors who hold MLTX?
          The average age of MLTX Holders is over 55.
            What other stocks have MLTX investors also bought?
            MLTX Investors also bought RIOT, TTD, MRVL, ANET, NVO, DKNG, UNH, NOW, MRK, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis